MET and cancer: PIM expression seems to be related to the mechanism of acquired resistance in MET inhibitor-resistant clones as the pan-PIM kinase inhibitor AZD1208 inhibits the development of resistant colonies despite having no effect on the growth of cancer cells, suggesting that PIM kinases play a role in the development of resistance to MET inhibitors [103].